Kexing Biopharm Co., Ltd. (SHA:688136)
30.78
+0.91 (3.05%)
Mar 10, 2026, 2:55 PM CST
46.36% (1Y)
| Market Cap | 5.92B |
| Revenue (ttm) | 1.54B |
| Net Income (ttm) | 159.44M |
| Shares Out | 198.11M |
| EPS (ttm) | 0.81 |
| PE Ratio | 36.88 |
| Forward PE | 27.40 |
| Dividend | 0.08 (0.27%) |
| Ex-Dividend Date | n/a |
| Volume | 2,606,853 |
| Average Volume | 2,535,757 |
| Open | 30.28 |
| Previous Close | 29.87 |
| Day's Range | 30.04 - 30.94 |
| 52-Week Range | 20.05 - 63.99 |
| Beta | 0.73 |
| RSI | 48.21 |
| Earnings Date | Mar 28, 2026 |